Varenicline for smoking cessation in schizophrenia: Safety and effectiveness in a 12-week open-label trial

Gladys N. Pachas, Corinne Cather, Sarah I. Pratt, Bettina Hoeppner, Johanna Nino, Sara V. Carlini, Eric D. Achtyes, Harry Lando, Kim T. Mueser, Nancy A. Rigotti, Donald C. Goff, A. Eden Evins

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Varenicline for smoking cessation in schizophrenia: Safety and effectiveness in a 12-week open-label trial'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Psychology